Neurosurgical products have broad prospects! Medical device segmentation is worthy of attention

Medical Network August 22nd With the development of the economy, population growth, the aging of the society, and the growing awareness of people's health care, the global medical device market continues to grow rapidly, and the medical device industry is the fastest growing in the world today. One of the industries. In 2017, the global medical device market is forecast to be 403 billion US dollars. By 2022, the global medical device market will reach 522 billion US dollars, and the CAGR annual growth rate will be 5.1% in 2016-2022. In comparison, the global prescription drug market will reach 77.7 billion US dollars in 2017, and will reach 1.043 trillion US dollars by 2022. CAGR will grow by 5.2% annually. In 2022, the device market accounts for about half of the global drug market. The growth rate is quite.

In terms of market size, the top rankings are as follows

In vitro diagnosis of InVitroDiagnostics

In 2016, the market size was 49.4 billion US dollars, CAGR 5.9% in 2016-2022, the largest scale, the second fastest growth rate.

In 2016, the market size was 44.6 billion US dollars, CAGR 5.7% in 2016-2022, the second largest, the third fastest growth rate.

Imaging DiagnosticImaging

In 2016, the market size was 39.2 billion US dollars, CAGR 3.4% in 2016-2022, the third largest, and the growth rate is tenth.

Orthopedics

In 2016, the market size was 35 billion US dollars, 2016-2022 CAGR 4.0%, the fourth largest, the growth rate ninth.

Ophthalmic Ophthalmics

In 2016, the market size was 26 billion US dollars, 2016-2022 CAGR 5.3%, the scale was the fifth, and the growth rate was the fifth.

General and plastic surgery General&plasticsurgery

In 2016, the market size was 20.4 billion US dollars, CAGR 5.3% in 2016-2022, the sixth scale, and the fifth fastest growth rate.

Endoscopy

In 2016, the market size was 17.8 billion US dollars, 2016-2022 CAGR 6.4%, the scale was the seventh, and the growth rate was the first.

Drug Transport DrugDelivery

In 2016, the market size was 18.6 billion US dollars, CAGR 4.8% in 2016-2022, the eighth largest, and the seventh fastest growth rate.

WoundManagement

In 2016, the market size was 13 billion US dollars, 2016-2022 CAGR 4.5%, the scale was ninth, and the growth rate was eighth.

Dental Dental

In 2016, the market size was 12.8 billion US dollars, 2016-2022 CAGR5.6%, the scale was 10th, and the growth rate was fourth.

Diabetes Diabetes

In 2016, the market size was 11 billion, and the CAGR of 2016-2022 was 6.6%.

Nephrology

In 2016, the market size was 11 billion, and the CAGR of 2016-2022 was 4.6%.

Hospital equipment and supplies GeneralHospital&HealthcareSupply

In 2016, the market size was 11 billion, and the CAGR of 2016-2022 was 2.5%.

ENT Ear, Nose & Throat (ENT)

In 2016, the market size was 8 billion, and the CAGR of 2016-2022 was 5.5%.

Neuroneology

In 2016, the market size was 7.4 billion, and the CAGR of 2016-2022 was 7.8%.

Specific to the field of neurosurgical instruments, with reference to the following rankings, it can be found that this segment is ranked 15th. Currently, the global neurosurgery planning and navigation market is huge, the potential global market size is 1.5 billion US dollars, and it is estimated that by 2020, the world The surgical navigation system market will grow at a compound annual growth rate of 4.5%. At home, the neurosurgery navigation market has great potential. In 2012, there were about 175 navigation systems on the market. According to Canadian NDI, China's neuronavigation system market capacity will reach 500. Around the Taiwan.

In this market, brain surgery planning and navigation products are currently in great demand. Looking at the US and global markets, there are 1,358 hospitals in the United States with neurosurgical departments (treatment > 332 suspects) Difficult disease Example of inpatients. In the installation of potential SRP (planning software), there are 3,500 surgical navigation systems for neurosurgery; in the potential SNAP (navigation software) installation, the main company on the market today is Stryker Stryker , Brainlab, Medtronic, GM, Siemens. By 2020, the global annual growth rate of the surgical navigation system market is expected to reach 4.5%.

The potential market size of the United States each year is as follows:

Note:

1 US 2012 new ranking

2 Calculated based on information from the Medtronic 2014 Investor Conference

3 Market transparent investigation of surgical navigation market

Take the Surgical Theater 3D Brain Navigation Project in the United States as an example: The company called Surgical Theater was founded in June 2010 and is headquartered in Cleveland, Ohio. Its planning system SRP and navigation system SNAP were in 2013. FDA certification in February and June 2014. Surgical Theater has completed the integration of its navigation platform SNAP and Medtronic's StealthStation navigation system, which has been exhibited at several US and world-class brain surgery conferences. At present, the number of operations using the SNAP system has exceeded 1,000. The number will continue to increase in the future. In 2015, the company has received a $5 million investment from HTC. In the future, the two companies will focus on developing medical VR virtual reality glasses to help doctors. Before surgery, intraoperative and postoperative, it is enough to be in the patient's brain, greatly improving the accuracy and minimally invasive surgery, reducing the recovery time and postoperative complications. In the fourth quarter of 2015, the company added the VR part to SNAP. In the system.

Its technical competitive advantage is outstanding. The image interface is clearer and more realistic than the largest competitors in the navigation market and the Medtronic and Brainlab systems. It has more perfect 3D effects and features such as tactile feedback. The mainstream navigation equipment is fully integrated. And the company's products are mature, have passed FDA, CE certification and sales, Mayo Clinic, Mount Sinai, UCLA and other US Famous doctor The hospital has already adopted its equipment, reflecting its technological advancement from the side.

On the other hand, the company's management team is experienced and structurally stable, including former Israeli Air Force R&D officials, engineers, and neurosurgery directors from many of the top US hospitals, including Mayo Clinic, Mount Sinai, and UCLA, as core opinion leaders. A forward-looking and practical combination of company technology.

At the annual meeting of Taiwan HTC Company on December 18, 2015, Surgical Theater's three-dimensional navigation technology was successfully demonstrated. As the main strategic investment direction of HTC in the future, VR's main core investment project was personally recommended by Ms. Wang Xuehong!

Surgical Theater now has two product lines. SRP - Neurosurgery preoperative planning system, which can use the patient's existing CT or MRI image data for image fusion processing and 3D reconstruction to generate realistic 3D brain stereo images, help doctors Observing the spatial relationship between the lesion and the surrounding tissue on the virtual image, selecting the best surgical tool, designing the optimal surgical approach and performing the surgical simulation to improve the safety of the operation. SNAP-neurological surgical navigation system, capable of mainstream surgery The navigation device fusion, combined with the 3D images previously generated in the planning system, helps doctors accurately locate and identify diseased tissues, highlight important blood vessels, nerves and other functional tissues, reduce damage to surrounding tissues, and improve the resection rate and surgical accuracy of the lesions. Reduce the risk of surgery. For example, the new generation of EndoSNAP products will enable doctors to see the endoscope's field of view when they use the endoscope, and also see the endoscopic field of view in the patient's brain 3D model in real time. Help the doctor to see the pathological tissue around the endoscope. This technique has been verified in UCLA and received good feedback.

Finally, why are such projects urgently needed in the current market?

Because the current surgical preparation is limited to observing pictures, and with the increase of instrument use, minimally invasive treatment, robot application, etc., the surgery becomes more and more complicated, and the detailed planning of the operation becomes a top priority. Now the level of surgical preparation is limited to ' Brain' planning; surgeons and hospital Performance is limited to personal experience. For this purpose, Surgical Theater specializes in patient-specific, FDA-approved, realistic 3D surgical planning and guidance.

In short, the market needs a good navigation system to improve the success rate of surgery, we can understand from the above figure.

In addition, in the Chinese market, the Department of Neurosurgery of Huashan Hospital affiliated to Fudan University introduced the first Medtronic StealthStation neuronavigation system in September 1997, opening the market for the Chinese neuronavigation system. Although the domestic neuronavigation market started late. However, the market potential is huge. With the economic foundation and technical strength of major hospitals, by the end of 2012, there are already 191 navigation systems, mainly concentrated in Beijing, Shanghai, Guangzhou and coastal developed areas. According to Canadian NDI company forecasts, domestic The neuronavigation system market capacity will reach about 500 units.

Other*: GE, Compass, Anke

At present, the domestic navigation market is dominated by imported equipment. The sales volume of Medtronic and Brainlab systems in China is 89 and 53 respectively, with a market share of 46.6% and 27.7%. Domestic equipment such as Fudan's Excelim-04 system The sales volume is 30 units and the market share is 15.7%.

Surgical Theater has received tens of millions of dollars in investments from HTC and Shanghai Chuangrui.